Logo image of TUSK

MAMMOTH ENERGY SERVICES INC (TUSK) Stock Fundamental Analysis

NASDAQ:TUSK - Nasdaq - US56155L1089 - Common Stock - Currency: USD

2.4  -0.13 (-5.14%)

After market: 2.4 0 (0%)

Fundamental Rating

3

TUSK gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 62 industry peers in the Energy Equipment & Services industry. TUSK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. TUSK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

TUSK had negative earnings in the past year.
In the past year TUSK had a positive cash flow from operations.
In the past 5 years TUSK always reported negative net income.
Of the past 5 years TUSK 4 years had a positive operating cash flow.
TUSK Yearly Net Income VS EBIT VS OCF VS FCFTUSK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

TUSK has a Return On Assets of -52.37%. This is amonst the worse of the industry: TUSK underperforms 98.39% of its industry peers.
TUSK has a Return On Equity of -77.64%. This is amonst the worse of the industry: TUSK underperforms 90.32% of its industry peers.
Industry RankSector Rank
ROA -52.37%
ROE -77.64%
ROIC N/A
ROA(3y)-18.17%
ROA(5y)-16.33%
ROE(3y)-27.61%
ROE(5y)-24.76%
ROIC(3y)N/A
ROIC(5y)N/A
TUSK Yearly ROA, ROE, ROICTUSK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

TUSK's Gross Margin of 11.41% is on the low side compared to the rest of the industry. TUSK is outperformed by 91.94% of its industry peers.
TUSK's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for TUSK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.88%
GM growth 5Y-6.79%
TUSK Yearly Profit, Operating, Gross MarginsTUSK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

5

2. Health

2.1 Basic Checks

TUSK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TUSK has been increased compared to 1 year ago.
The number of shares outstanding for TUSK has been increased compared to 5 years ago.
TUSK has a better debt/assets ratio than last year.
TUSK Yearly Shares OutstandingTUSK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
TUSK Yearly Total Debt VS Total AssetsTUSK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

TUSK has an Altman-Z score of -0.73. This is a bad value and indicates that TUSK is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.73, TUSK is not doing good in the industry: 88.71% of the companies in the same industry are doing better.
The Debt to FCF ratio of TUSK is 0.08, which is an excellent value as it means it would take TUSK, only 0.08 years of fcf income to pay off all of its debts.
TUSK's Debt to FCF ratio of 0.08 is amongst the best of the industry. TUSK outperforms 95.16% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that TUSK is not too dependend on debt financing.
TUSK has a better Debt to Equity ratio (0.03) than 87.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.08
Altman-Z -0.73
ROIC/WACCN/A
WACC16.28%
TUSK Yearly LT Debt VS Equity VS FCFTUSK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.78 indicates that TUSK should not have too much problems paying its short term obligations.
TUSK has a Current ratio of 1.78. This is comparable to the rest of the industry: TUSK outperforms 43.55% of its industry peers.
TUSK has a Quick Ratio of 1.62. This is a normal value and indicates that TUSK is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.62, TUSK perfoms like the industry average, outperforming 59.68% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.62
TUSK Yearly Current Assets VS Current LiabilitesTUSK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for TUSK have decreased strongly by -404.55% in the last year.
The Revenue for TUSK has decreased by -12.34% in the past year. This is quite bad
Measured over the past years, TUSK shows a very negative growth in Revenue. The Revenue has been decreasing by -21.36% on average per year.
EPS 1Y (TTM)-404.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96%
Revenue 1Y (TTM)-12.34%
Revenue growth 3Y-6.38%
Revenue growth 5Y-21.36%
Sales Q2Q%44.63%

3.2 Future

TUSK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.69% yearly.
The Revenue is expected to grow by 9.81% on average over the next years. This is quite good.
EPS Next Y87.98%
EPS Next 2Y40.69%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.95%
Revenue Next 2Y9.81%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
TUSK Yearly Revenue VS EstimatesTUSK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
TUSK Yearly EPS VS EstimatesTUSK Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 4 -4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TUSK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TUSK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TUSK Price Earnings VS Forward Price EarningsTUSK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, TUSK is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 1
EV/EBITDA N/A
TUSK Per share dataTUSK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

TUSK's earnings are expected to grow with 40.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.69%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TUSK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAMMOTH ENERGY SERVICES INC

NASDAQ:TUSK (5/23/2025, 9:00:33 PM)

After market: 2.4 0 (0%)

2.4

-0.13 (-5.14%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)08-07 2025-08-07
Inst Owners78.25%
Inst Owner Change-0.4%
Ins Owners2.28%
Ins Owner Change-0.06%
Market Cap115.51M
Analysts85.71
Price Target4.28 (78.33%)
Short Float %1.26%
Short Ratio3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-17.49%
Min EPS beat(2)-124.09%
Max EPS beat(2)89.11%
EPS beat(4)1
Avg EPS beat(4)-2319.86%
Min EPS beat(4)-4801.96%
Max EPS beat(4)89.11%
EPS beat(8)1
Avg EPS beat(8)-1285.34%
EPS beat(12)4
Avg EPS beat(12)-613.35%
EPS beat(16)4
Avg EPS beat(16)-529.52%
Revenue beat(2)2
Avg Revenue beat(2)46.09%
Min Revenue beat(2)31.99%
Max Revenue beat(2)60.19%
Revenue beat(4)3
Avg Revenue beat(4)23.22%
Min Revenue beat(4)-16.85%
Max Revenue beat(4)60.19%
Revenue beat(8)3
Avg Revenue beat(8)2.42%
Revenue beat(12)5
Avg Revenue beat(12)4.94%
Revenue beat(16)5
Avg Revenue beat(16)0.83%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.56
P/FCF 1
P/OCF 0.85
P/B 0.46
P/tB 0.47
EV/EBITDA N/A
EPS(TTM)-2.22
EYN/A
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)2.41
FCFY100.37%
OCF(TTM)2.83
OCFY117.81%
SpS4.31
BVpS5.25
TBVpS5.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -52.37%
ROE -77.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.41%
FCFM 55.95%
ROA(3y)-18.17%
ROA(5y)-16.33%
ROE(3y)-27.61%
ROE(5y)-24.76%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.88%
GM growth 5Y-6.79%
F-Score4
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.08
Debt/EBITDA N/A
Cap/Depr 88.65%
Cap/Sales 9.72%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 1.62
Altman-Z -0.73
F-Score4
WACC16.28%
ROIC/WACCN/A
Cap/Depr(3y)44.95%
Cap/Depr(5y)29.88%
Cap/Sales(3y)6.28%
Cap/Sales(5y)4.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-404.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96%
EPS Next Y87.98%
EPS Next 2Y40.69%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.34%
Revenue growth 3Y-6.38%
Revenue growth 5Y-21.36%
Sales Q2Q%44.63%
Revenue Next Year-5.95%
Revenue Next 2Y9.81%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-206.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year108.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3309.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y551.1%
OCF growth 3YN/A
OCF growth 5YN/A